Max Healthcare recommends Rs 2 per share dividend for FY26

Arunika Jain — Thu, 21 May 2026 11:17:56 +0000

Max Healthcare Institute’s board of directors has approved several key resolutions during its meeting held on 21 May 2026. Among the significant decisions, the board recommended a final dividend of ₹2 per equity share for the financial year 2025-26. This dividend, representing 20% of the face value of ₹10 per share, is subject to approval at the upcoming Annual General Meeting (AGM) and will be distributed within 30 days post-AGM.

The board also approved the audited financial results for the fourth quarter and financial year ending 31 March 2026. The financial results were audited by M/s. S.R. Batliboi & Co. LLP, Chartered Accountants, and were recommended by the Audit Committee. The auditor’s report, which accompanies the financial results, was issued with an unmodified opinion.

In addition to financial matters, the board approved the re-appointment of M/s. Chandra Wadhwa & Co. as Cost Auditors for the financial year 2026-27. This decision follows the recommendation of the Audit Committee.

The board also considered and approved the re-classification request from Radiant Life Care Hospital Foundation, seeking to move from ‘Promoter Group’ to ‘Public’ category. This re-classification is contingent upon receiving approval and a no-objection letter from the relevant stock exchanges.

Another significant approval was granted for the construction of Phase-I of the Max Super Specialty Hospital at Shaheed Path, Lucknow. The hospital, to be built on a 5-acre land parcel owned by the company, will have a capacity of approximately 712 census beds.

Further, the board approved the shifting of the company’s registered office from Mumbai, Maharashtra to Gurugram, Haryana, pending approval from members at the forthcoming AGM and other regulatory authorities.

The board also re-appointed Mr. Anil Kumar Bhatnagar as a Non-Executive and Non-Independent Director for a term of three years, effective from 1 October 2026 to 30 September 2029. Mr. Bhatnagar’s re-appointment is subject to member approval at the AGM.

The board meeting commenced at 12:07 PM and concluded at 3:44 PM. The resolutions and decisions will be available on the company’s official website.

Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).

Max Healthcare Institute approves ₹2 per share dividend and plans new hospital construction

Business Desk — Thu, 21 May 2026 11:14:30 +0000

Max Healthcare Institute has announced a series of significant decisions following its board meeting held on May 21, 2026. Key outcomes include the approval of a final dividend, the re-appointment of auditors, and plans for new hospital construction.

The board approved a final dividend of ₹2 per equity share, representing 20% of the face value of ₹10 each, for the financial year 2025-26. This dividend is subject to the approval of shareholders at the upcoming Annual General Meeting (AGM) and will be paid within 30 days of the meeting’s conclusion.

In addition to the dividend, the board has approved the re-appointment of M/s. Chandra Wadhwa & Co. as the cost auditors for the financial year 2026-27. This decision follows the recommendation of the Audit Committee.

The board also approved the re-classification of Radiant Life Care Hospital Foundation from the ‘Promoter Group’ to the ‘Public’ category, pending approval from the relevant stock exchanges. This move aligns with regulatory requirements under SEBI Listing Regulations.

A significant development is the board’s approval for the construction of Phase-I of Max Super Specialty Hospital in Lucknow. The hospital will be built on a 5-acre land parcel owned by the company at Shaheed Path, with a capacity to accommodate approximately 712 beds.

Furthermore, the board has decided to shift the company’s registered office from Mumbai, Maharashtra to Gurugram, Haryana, subject to necessary approvals.

The board has also re-appointed Mr. Anil Kumar Bhatnagar as a Non-Executive and Non-Independent Director for a three-year term starting October 1, 2026. This re-appointment is contingent upon approval at the forthcoming AGM.

Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).

Chandra Wadhwa & Co. | Business Upturn

Max Healthcare recommends Rs 2 per share dividend for FY26

Max Healthcare Institute approves ₹2 per share dividend and plans new hospital construction